Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Axium Healthcare Pharmacy is recalling Trimix injectable vials due to a lack of assurance of sterility and quality control concerns.
Axium Healthcare Pharmacy is recalling Triamcinolone Hexacetonide Injectable vials due to a lack of assurance of sterility and quality control concerns.
Axium Healthcare Pharmacy is recalling Sodium Tetradecyl Sulfate Injectable due to lack of sterility assurance and quality control concerns.
Axium Healthcare Pharmacy is recalling DMSO 50% Sterile Bladder Irrigation Solution because the company cannot ensure the product is sterile.
Sandoz is recalling specific lots of Amoxicillin Capsules USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.
Qualitest Pharmaceuticals is recalling 10,373 bottles of Glimepiride 2 mg tablets because one oversized tablet was found in a sealed bottle at the retail level.
OPMX, LLC is recalling Pentrexcilina tablets because the labels are misleading and may be confused with a prescription antibiotic.
OPMX, LLC is recalling Pentrexcilina Jarabe NF liquid because its label may be confused with Pentrexyl, a prescription antibiotic.
Hospira Inc. is recalling 245,250 vials of Propofol Injectable Emulsion because a single visible particulate was found during a retain sample inspection.
Mylan Pharmaceuticals is recalling 2,405 bottles of Lisinopril 10 mg tablets because the pills have the wrong ID code imprinted on them.
Hospira is recalling Lactated Ringer's and 5% Dextrose Injection due to a confirmed report of non-sterility involving spore-like particulates consistent with mold.
Body Basics Inc is recalling Actra-SX 500 capsules because they contain sildenafil, an active ingredient in FDA-approved erectile dysfunction drugs, without an approved NDA or ANDA.
The Menz Club is recalling Blue Male Enhancement Pill because it contains sulfoaildenafil, an unapproved analogue of sildenafil.
Hospira is recalling 143,136 units of Lactated Ringer's and 5% Dextrose Injection due to confirmed mold contamination.
Teva Pharmaceuticals is recalling 6,692 boxes of Copaxone (glatiramer acetate) injection due to visible medical grade silicone oil in the syringes.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Precision Dose Inc. is recalling Children's Acetaminophen Oral Suspension because the label is misleading. The product contains an adult dose of acetaminophen despite the name.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl (levothyroxine sodium) tablets because they emit a strong chemical odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after opening. The recall covers 10,121 bottles distributed nationwide and in Puerto Rico.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong chemical odor after the package is opened.